Address
2 Tower Place
Suite 2000
South San Francisco CA
94080 United States
Contact
Adam Watts+331 60 92 42 40
eu.customerservice@standardbio.com
Website
Pathogen & ARG Detection via Microfluidic PCR
Researchers and public health institutes worldwide use our Biomark X9 microfluidics genomics system to monitor multiple ARGs and pathogens simultaneously with a high-throughput, flexible, and robust protocol
Based on microfluidic technology we can test for hundreds of samples for hundreds of different assays simultaneously to identify AMR genes and pathogens to better understand the ecosystem that is being analysed.
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Marketed product
- Research
- Development
- Validation
- Market entry
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- Sell
- License
- Co-develop
- Outsource
- Joint Venture
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- North America
- South America
- Eurasia
- Africa
- Oceania
N.A.
At Standard BioTools™ we focus on the most pressing needs in translational and clinical research. With automated qPCR and NGS workflows, we provide an unprecedented view into health and disease. Learn how to set the new benchmarks in automated, cost-effective quantitative PCR and NGS assays with the Biomark X9™ systems by reducing cost and hands-on time with walk-away automation.
N/A
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!